| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0010100 | Intron-Intron | chr10:31650774-31651144 | chr10:31361845-31362215 | 371 nt | 0.6927 |
| hsa_ZEB1_0010200 | Intron-Exon-Intron | chr10:31654902-31676727 | chr10:31365973-31387798 | 250 nt | 0.3280 |
| hsa_ZEB1_0010300 | Intron-Intron | chr10:31655055-31655866 | chr10:31366126-31366937 | 812 nt | 0.3953 |
| hsa_ZEB1_0010400 | Intron-Exon-Intron | chr10:31661881-31676195 | chr10:31372952-31387266 | 527 nt | 0.3871 |
| hsa_ZEB1_0010500 | Intron-Exon-Intron | chr10:31661881-31676727 | chr10:31372952-31387798 | 1059 nt | 0.3862 |
| hsa_ZEB1_0010600 | Intron-Exon-Intron | chr10:31661933-31676195 | chr10:31373004-31387266 | 170 nt | 0.3706 |
| hsa_ZEB1_0010700 | Intron-Exon-Intron | chr10:31661933-31676727 | chr10:31373004-31387798 | 79 nt | 0.3671 |
| hsa_ZEB1_0010800 | Intron-Exon-Intron | chr10:31661933-31677304 | chr10:31373004-31388375 | 141 nt | 0.3475 |
| hsa_ZEB1_0010900 | Intron-Exon-Intron | chr10:31661933-31750166 | chr10:31373004-31461237 | 450 nt | 0.3956 |
| hsa_ZEB1_0011000 | Intron-Exon-Intron | chr10:31661933-31791437 | chr10:31373004-31502509 | 162 nt | 0.4383 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].